Clinic for Internal Medicine, HELIOS Klinik Zwenkau, Zwenkau, Germany.
German National Reference Laboratory for Tularaemia, Department of Immunology, Bundeswehr Institute of Microbiology, München, Germany.
J Med Microbiol. 2010 Sep;59(Pt 9):1123-1125. doi: 10.1099/jmm.0.019893-0. Epub 2010 Jun 3.
This case of pneumonic tularaemia elucidates two aspects: it is believed to be the first documented case of bacteraemia caused by Francisella tularensis subsp. holarctica biovar II; furthermore, it illustrates the remission of septic pneumonic tularaemia without appropriate anti-infective therapy. A blood culture from a patient with community-acquired pneumonia was found to be positive for F. tularensis subsp. holarctica biovar II after 10 days of cultivation. Meanwhile, the patient had been treated with ceftriaxone, followed by sultamicillin and clindamycin. The patient continued suffering from fever of up to 40.7 degrees C and rising C-reactive protein (CRP) for 4 days before the fever and CRP declined. The isolated strain was later tested and found to be resistant to the antibiotics used. The present case underlines that F. tularensis subsp. holarctica infections may cause severe symptoms but mostly have a favourable outcome.
据信这是首例由土拉弗朗西斯菌亚种 holarctica 生物型 II 引起菌血症的记录病例;此外,它说明了在没有适当抗感染治疗的情况下,败血性肺炎性土拉热会自行缓解。从一名患有社区获得性肺炎的患者的血液培养物中,在培养 10 天后发现了土拉弗朗西斯菌亚种 holarctica 生物型 II 呈阳性。同时,患者曾接受头孢曲松治疗,随后改用舒他西林和克林霉素。在发热和 CRP 下降之前,患者持续发热,体温高达 40.7 摄氏度,CRP 持续升高,持续了 4 天。后来对分离株进行了检测,发现该菌株对所用抗生素具有耐药性。本病例强调了土拉弗朗西斯菌亚种 holarctica 感染可能引起严重症状,但大多数情况下预后良好。